Evidence map›Paper›PMID 29633156›Full record

ArticleTranslational stroke research2018

Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical.

Gregory J Bix, Justin F Fraser, William J Mack, S Thomas Carmichael, Miguel Perez-Pinzon, Halina Offner, Lauren Sansing, Francesca Bosetti, Cenk Ayata, Keith R Pennypacker

Abstract read
In one paragraph

Article in Translational stroke research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Targeting Parthanatos in Ischemic Stroke.Frontiers in neurology · 2021
    Review
  10. Biomarker Application for Precision Medicine in Stroke.Translational stroke research · 2020
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gregory J BixCenter for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, USA.
Justin F FraserCenter for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, USA.
William J MackDepartment of Neurosurgery, Keck School of Medicine, University of Southern California, California, Los Angeles, USA.
S Thomas CarmichaelDepartment of Neurology, David Geffen School of Medicine, University of California at Los Angeles, California, Los Angeles, USA.
Miguel Perez-PinzonDepartment of Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Halina OffnerDepartment of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
Lauren SansingDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Francesca BosettiNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Cenk AyataDepartment of Neurology, Harvard Medical School, Charlestown, MA, USA.
Keith R PennypackerCenter for Advanced Translational Stroke Science, University of Kentucky, Lexington, KY, USA. keith.pennypacker@uky.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Sex differences in brain inflammation in experimental strokeR01NS076013 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI OFFNER, HALINA, SAUGSTAD, JULIE ANNE · 2012 to 2016
$2.3M
6 · The paper itself

Abstract

The first annual Stroke Translational Research Advancement Workshop (STRAW), entitled "Uncovering the Rosetta Stone: Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical" was held at the University of Kentucky on October 4-5, 2017. This workshop was organized by the Center for Advanced Translational Stroke Science. The workshop consisted of 2 days of activities. These included three presentations establishing the areas of research in stroke therapeutics, discussing the routes for translation from bench to bedside, and identifying successes and failures in the field. On day 2, grant funding opportunities and goals for the National Institute for Neurological Diseases and Stroke were presented. In addition, the meeting also included break-out sessions designed to connect researchers in areas of stroke, and to foster potential collaborations. Finally, the meeting concluded with an open discussion among attendees led by a panel of experts.

Indexed as

Congresses as TopicDisease Models, AnimalTranslational Research, BiomedicalAnimalsBrain IschemiaHumansStrokeAnimal modelsBrain ischemiaClinical trialsReverse translationThrombectomy

Identifiers

PMID29633156
PMCPMC5982459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.